Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 44, Issue 3

Issues

Comparison of the lipid profile and lipoprotein(a) between sedentary and highly trained subjects

Giuseppe Lippi
  • Istituto di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche, Università degli Studi di Verona, Verona, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Federico Schena
  • Centro Interuniversitario di Ricerca in Bioingegneria e Scienze Motorie, Rovereto (TN), Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Gian Luca Salvagno
  • Istituto di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche, Università degli Studi di Verona, Verona, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Martina Montagnana
  • Istituto di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche, Università degli Studi di Verona, Verona, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Filippo Ballestrieri
  • Centro Interuniversitario di Ricerca in Bioingegneria e Scienze Motorie, Rovereto (TN), Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Gian Cesare Guidi
  • Istituto di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche, Università degli Studi di Verona, Verona, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2011-09-21 | DOI: https://doi.org/10.1515/CCLM.2006.056

Abstract

Background: There is consolidated evidence that physical activity exerts beneficial effects on several chronic conditions and longevity, on the basis of its proposed biological effects, especially on lipid profiles. However, debate continues regarding the intensity of activity required for good health, as vigorous physical activity might overwhelm advantageous changes. In addition, little is known so far on the effect of a vigorous and regular aerobic training regimen on emerging markers of cardiovascular risk, such as lipoprotein(a), total/high-density lipoprotein cholesterol ratio and the atherogenic index of plasma.

Methods: To further investigate this topic, an extensive lipid profile, in accordance with the most recent guidelines issued by the American Heart Association (AHA)/American College of Cardiology (ACC) and the National Cholesterol Education Program (NCEP), was evaluated in 60 healthy male sedentary controls and in a wide population of professional endurance athletes, including 40 male professional cross-country skiers and 102 male professional road cyclists.

Results: Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), triglycerides, TC low-density lipoprotein cholesterol (LDL-C) ratio and the atherogenic index of plasma were significantly lower in both categories of professional athletes, whereas the mean HDL-C concentration was significantly higher. The concentration of lipoprotein(a) did not differ significantly between the groups. When compared to current NCEP or AHA/ACC goals, the percentage of patients with undesirable values was statistically different for all parameters tested, apart from lipoprotein(a). According to multiple stepwise logistic regression analysis, lower TC/HDL-C ratio in professional skiers and lower TC/HDL-C ratio and TC in professional cyclists were significantly associated with increased aerobic physical activity.

Conclusions: Results of this case-control study confirm that elevated aerobic energy expenditure might be associated with a highly favorable stabilization of most traditional and emerging cardiovascular risk predictors. Therefore, a substantial increase in aerobic physical activity within the population might be recommended to reverse adverse lipid abnormalities, especially in subjects with a higher cardiovascular risk.

Keywords: aerobic training; cardiovascular disease; lipid profile; lipoprotein(a); physical activity; sports

References

  • 1.

    Blair SN, LaMonte MJ, Nichaman MZ. The evolution of physical activity recommendations: how much is enough? Am J Clin Nutr 2004; 79:913S–20S.Google Scholar

  • 2.

    McKechnie R, Mosca L. Physical activity and coronary heart disease: prevention and effect on risk factors. Cardiol Rev 2003; 11:21–5.CrossrefGoogle Scholar

  • 3.

    Go VL, Wong DA, Wang Y, Butrum RR, Norman HA, Wilkerson L. Diet and cancer prevention: evidence-based medicine to genomic medicine. J Nutr 2004; 134(Suppl 12):3513S–16S.Google Scholar

  • 4.

    Painter P. Exercise for patients with chronic disease: physician responsibility. Curr Sports Med Rep 2003; 2:173–80.CrossrefGoogle Scholar

  • 5.

    Manson JE, Hu FB, Rich-Edwards JW, Colditz GA, Stampfer MJ, Willett WC, et al. A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med 1999; 341:650–8.Google Scholar

  • 6.

    Tanasescu M, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Exercise type and intensity in relation to coronary heart disease in men. J Am Med Assoc 2002; 288:1994–2000.Google Scholar

  • 7.

    Lee IM, Sesso HD, Oguma Y, Paffenbarger RS Jr. Relative intensity of physical activity and risk of coronary heart disease. Circulation 2003; 107:1110–6.Google Scholar

  • 8.

    Fletcher GF, Blair SN, Blumenthal J, Caspersen C, Chaitman B, Epstein S, et al. Statement on exercise. Benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation 1992; 86:340–4.Google Scholar

  • 9.

    NIH Consensus Development Panel on Physical Activity and Cardiovascular Health. Physical activity and cardiovascular health. J Am Med Assoc 1996;276:241–6.Google Scholar

  • 10.

    Burtscher M, Pachinger O, Mittleman MA, Ulmer H. Prior myocardial infarction is the major risk factor associated with sudden cardiac death during downhill skiing. Int J Sports Med 2000; 21:613–5.CrossrefGoogle Scholar

  • 11.

    Hosey RG, Armsey TD. Sudden cardiac death. Clin Sports Med 2003; 22:51–66.Web of ScienceCrossrefGoogle Scholar

  • 12.

    Maron BJ, Chaitman BR, Ackerman MJ, Bayes de Luna A, Corrado D, Crosson JE, et al., Working Groups of the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention; Councils on Clinical Cardiology and Cardiovascular Disease in the Young. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 2004; 109:2807–16.Google Scholar

  • 13.

    Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 1999; 100:1481–92.CrossrefGoogle Scholar

  • 14.

    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001;285:2486–97.Google Scholar

  • 15.

    Sih BL, Stuhmiller JH. The metabolic cost of force generation. Med Sci Sports Exerc 2003; 35:623–9.CrossrefGoogle Scholar

  • 16.

    Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499–502.Google Scholar

  • 17.

    Dobiasova M. Atherogenic index of plasma [log(tri-glycerides/HDL–cholesterol)]: theoretical and practical implications. Clin Chem 2004; 50:1113–5.CrossrefGoogle Scholar

  • 18.

    Brukner PD, Brown WJ. Is exercise good for you? Med J Aust 2005; 183:538–41.Google Scholar

  • 19.

    Durstine JL, Thompson PD. Exercise in the treatment of lipid disorders. Cardiol Clin 2001; 19:471–88.CrossrefGoogle Scholar

  • 20.

    Drygas W, Kostka T, Jegier A, Kunski H. Long-term effects of different physical activity levels on coronary heart disease risk factors in middle-aged men. Int J Sports Med 2000; 21:235–41.CrossrefGoogle Scholar

  • 21.

    Sgouraki E, Tsopanakis A, Kioussis A, Tsopanakis C. Acute effects of short duration maximal endurance exercise on lipid, phospholipid and lipoprotein levels. J Sports Med Phys Fitness 2004; 44:444–50.Google Scholar

  • 22.

    Mackinnon LT, Hubinger LM. Effects of exercise on lipoprotein(a). Sports Med 1999; 28:11–24.CrossrefGoogle Scholar

  • 23.

    Lippi G, Guidi G. Lipoprotein(a): an emerging cardiovascular risk factor. Crit Rev Clin Lab Sci 2003; 40:1–42.CrossrefGoogle Scholar

  • 24.

    Lippi G, Braga V, Adami S, Guidi G. Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein(a) levels after bisphosphonates-induced acute phase response. Clin Chim Acta 1998; 271:79–87.Google Scholar

  • 25.

    Ramharack R, Barkalow D, Spahr MA. Dominant negative effect of TGF-β1 and TNF-α on basal and IL-6-induced lipoprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures. Arterioscler Thromb Vasc Biol 1998; 18:984–90.Google Scholar

  • 26.

    Byrne DJ, Jagroop IA, Montgomery HE, Thomas M, Mikhailidis DP, Milton NG, et al. Lipoprotein(a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk. J Clin Pathol 2002; 55:280–5.CrossrefGoogle Scholar

  • 27.

    Kinosian B, Glick H, Garland G. Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med 1994; 121:641–7.Google Scholar

  • 28.

    Kelley GA, Kelley KS, Tran ZV. Walking, lipids, and lipo-proteins: a meta-analysis of randomized controlled trials. Prev Med 2004; 38:651–61.CrossrefGoogle Scholar

  • 29.

    Twisk JW, Kemper HC, van Mechelen W. Prediction of cardiovascular disease risk factors later in life by physical activity and physical fitness in youth: introduction. Int J Sports Med 2002; 23(Suppl 1):S5–7.Google Scholar

  • 30.

    Boreham C, Twisk J, Neville C, Savage M, Murray L, Gallagher A. Associations between physical fitness and activity patterns during adolescence and cardiovascular risk factors in young adulthood: the Northern Ireland Young Hearts Project. Int J Sports Med 2002; 23(Suppl 1):S22–6.CrossrefGoogle Scholar

  • 31.

    Janz KF, Dawson JD, Mahoney LT. Increases in physical fitness during childhood improve cardiovascular health during adolescence: the Muscatine Study. Int J Sports Med 2002; 23(Suppl 1):S15–21.CrossrefGoogle Scholar

  • 32.

    Twisk JW, Kemper HC, van Mechelen W. The relationship between physical fitness and physical activity during adolescence and cardiovascular disease risk factors at adult age. The Amsterdam Growth and Health Longitudinal Study. Int J Sports Med 2002; 23(Suppl 1):S8–14.CrossrefGoogle Scholar

  • 33.

    Duscha BD, Slentz CA, Johnson JL, Houmard JA, Bensimhon DR, Knetzger KJ, et al. Effects of exercise training amount and intensity on peak oxygen consumption in middle-age men and women at risk for cardiovascular disease. Chest 2005; 128:2788–93.Google Scholar

About the article

Corresponding author: Prof. Giuseppe Lippi, Istituto di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche, Ospedale Policlinico G.B. Rossi, Piazzale Scuro, 10, 37134 Verona, Italy Fax: +39-045-8201889,


Received: 2005-09-27

Accepted: 2005-12-13

Published Online: 2011-09-21

Published in Print: 2006-03-01


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 44, Issue 3, Pages 322–326, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2006.056.

Export Citation

©2006 by Walter de Gruyter Berlin New York. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Carmen G. C. Vinagre, Elisabeth S. Ficker, Claudia Finazzo, Maria J. N. Alves, Katia de Angelis, Maria Claudia Irigoyen, Carlos E. Negrão, and Raul C. Maranhão
Journal of Applied Physiology, 2007, Volume 103, Number 4, Page 1166
[2]
Thomas Schöndorf, Andreas Pfützner, Georg Lübben, Efstrathios Karagiannis, Werner Roth, and Thomas Forst
Journal of Diabetes Science and Technology, 2008, Volume 2, Number 2, Page 244
[3]
Tracie C Collins and Philip Twumasi-Ankrah
SAGE Open Medicine, 2013, Volume 1, Page 205031211350555
[4]
Aline Margioti Zanella, Marcelo Arruda Nakazone, Marcela Augusta Souza Pinhel, and Dorotéia Rossi Silva Souza
Arquivos Brasileiros de Endocrinologia & Metabologia, 2011, Volume 55, Number 2, Page 121
[5]
NATHÁLIA M. RESENDE, HENRIQUE R. FÉLIX, MURILLO R. SORÉ, ANÍBAL M.M. NETO, KLEBER E. CAMPOS, and GUSTAVO T. VOLPATO
Anais da Academia Brasileira de Ciências, 2016, Volume 88, Number 2, Page 933
[6]
Robert Nowak, Dorota Kostrzewa-Nowak, Zbigniew Jastrzębski, Aleksandra Zarębska, Krzysztof Ficek, and Paweł Cięszczyk
Human Movement, 2016, Volume 17, Number 4
[7]
M. Djelic, S. Mazic, B. Lazovic, D. Zikic, M. Sumarac-Dumanovic, and D. Micic
Science & Sports, 2015, Volume 30, Number 6, Page 321
[8]
Kevin M. Conley, Delmas J. Bolin, Peter J. Carek, Jeff G. Konin, Timothy L. Neal, and Danielle Violette
Journal of Athletic Training, 2014, Volume 49, Number 1, Page 102
[9]
Mika Venojärvi, Ayhan Korkmaz, Niko Wasenius, Sirpa Manderoos, Olli J. Heinonen, Harri Lindholm, Sirkka Aunola, Johan G. Eriksson, and Mustafa Atalay
Food and Chemical Toxicology, 2013, Volume 61, Page 127
[11]
Y.A. Carpentier and R.S. Komsa-Penkova
e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism, 2011, Volume 6, Number 6, Page e272
[12]
Meghan E. Short, Ron Z. Goetzel, Jared S. Young, Niranjana M. Kowlessar, Rivka C. Liss-Levinson, Maryam J. Tabrizi, Enid Chung Roemer, Adriano A. Sabatelli, Keith Winick, Myrtho Montes, and K. Andrew Crighton
Journal of Occupational and Environmental Medicine, 2010, Volume 52, Number 8, Page 797
[13]
Tineke Scheers, Renaat Philippaerts, Leen Van Langendonck, William Duquet, Nathalie Duvigneaud, Lynn Matton, Martine Thomis, Katrien Wijndaele, and Johan Lefevre
Public Health Nutrition, 2008, Volume 11, Number 11
[14]
Susanne Ring-Dimitriou, Serge P. von Duvillard, Bernhard Paulweber, Monika Stadlmann, Linda M. LeMura, Kayla Peak, and Erich Mueller
European Journal of Applied Physiology, 2007, Volume 99, Number 3, Page 291

Comments (0)

Please log in or register to comment.
Log in